Skip to content
Screener

Neuronetics STIM Total Revenue

Total Revenue at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
$435.35M+26.1%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$22.83M+17.1%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$12.13M+42.9%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$210.93M+3.8%
Stereotaxis logo
StereotaxisSTXS
$7.67M-12.8%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$814.5M+42.2%

Segments

By segment

See full
Greenbrook$26.89M
Neurostar$14.68M

By geography

See full
Non Us$1M+100%

By product

See full
Service$26.89M

Other financials

Income statement

See full
Gross profit$21.2M+19.5%
Operating income-$1.5M+81.4%
Net income-$3.4M+66.0%
EPS (diluted)-$0.05+66.7%

Balance sheet

See full
Cash & equivalents$19.2M+75.0%
Total debt$86.5M+7.3%
Total equity$17.9M-34.2%
Total assets$131.5M-2.3%

Cash flow

See full
Operating cash flow-$1.0M+71.2%
CapEx$417.0K+65.5%
Free cash flow-$1.4M+62.1%

Valuation

See full
Market cap$210.3M+11.6%
Enterprise value$277.63M+7.5%
P/S1.4×-0.3×

Profitability

See full
Gross margin49.1%-7.0pp
Operating margin-14.7%-5.4pp
Net margin-19.6%-7.0pp
FCF margin-7.7%-3.3pp

Returns & leverage

See full
Return on equity-135.3%-35.4pp
Debt / equity4.8×+1.9×
Current ratio1.9×-0.1×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Neuronetics’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:26 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-094078
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Revenues
NeuroStar$14,677$15,084$27,602$28,400
Greenbrook26,89123,02448,42041,683
Total revenue41,56838,10876,02270,083
Cost of revenues
NeuroStar3,3124,3116,1707,461
Greenbrook17,03316,03932,47529,126
Total cost of revenues20,34520,35038,64536,587

Item 1. Financial Statements.

FAQ

What is Neuronetics's total revenue?
Neuronetics (STIM) reported total revenue of $41.57M in Q2 2026.
How has Neuronetics's total revenue changed year-over-year?
Neuronetics's total revenue increased by 9.1% year-over-year, from $38.11M to $41.57M.
What is the long-term trend for Neuronetics's total revenue?
Over 4 years (2021 to 2025), Neuronetics's total revenue has grown at a 28.1% compound annual growth rate (CAGR), from $55.31M to $149.16M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Neuronetics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude